NCT03225781

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

A Clinical Trial Using Electrochemotherapy With Bleomycin for the Treatment of Non-metastatic Unresectable Pancreatic Cancer

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: Universita di Verona · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Electrochemotherapy is a type of electroporation that allows the delivery of drugs to the cells through the local creation of pores in the cell membrane. The electric pulses can be applied directly to the neoplastic cells, allowing for the local concentration of a possible chemotherapeutic agent administered through the bloodstream. This technique does not use heat nor other thermal energies and it is performed using special needles/electrodes linked to a generator ("porator"). In this study this technique will be applied on unresectable pancreatic cancer, already submitted to neoadjuvant treatment and still unresectable, through laparotomy. Bleomycin will be the chemotherapeutic agent.

Conditions

• Pancreatic Cancer

Interventions

Type	Name	Description
DEVICE	Electrochemotherapy with Bleomycin	Application of Reversible Electroporation (Electrochemotherapy) with Bleomycin

Timeline

• Start date: 2017-07-01
• Primary completion: 2018-12-21
• Completion: 2018-12-21
• First posted: 2017-07-21
• Last updated: 2018-12-26

Locations

1 site across 1 country: Italy